Investigation of Genetic Determinants of Capecitabine Toxicity
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL
Conditions: Breast Cancer
Interventions: OTHER: Side-effect questionnaires|OTHER: research blood samples
Sponsor: University of Chicago
Collaborators: Translational Breast Cancer Research Consortium|National Institutes of Health (NIH)